Trial Profile
Lack of Response to Vaccination in MGUS and Stable Myeloma
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 11 Dec 2009
Price :
$35
*
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary) ; Lenalidomide (Primary) ; Hepatitis B vaccine
- Indications Hepatitis B
- Focus Pharmacodynamics
- 08 Dec 2009 Interim results presented at the 51st Annual Meeting and Exposition of the American Society of Hematology.
- 03 Dec 2009 New trial record